
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SKIP CRISPR/Cas9 KO Plasmid (h) | sc-407373 | 20 µg | $397.00 |
INPP5K encodes the inositol polyphosphate-5-phosphatase K, commonly referred to as SKIP, a phosphoinositide phosphatase that regulates cellular phosphoinositol signaling by dephosphorylating PtdIns(4,5)P₂ and related substrates. By tuning phosphoinositide composition at membranes, SKIP influences actin cytoskeleton organization, membrane trafficking, and signal transduction downstream of pathways such as PI3K/AKT that depend on localized lipid second messengers. Altered INPP5K activity has been linked to disruptions in muscle and neurodevelopmental homeostasis, making it relevant to studies of congenital disorders affecting neuromuscular function and cellular architecture. Because phosphoinositides coordinate multiple compartments and processes, SKIP serves as a useful node for dissecting membrane–cytoskeleton coupling and phosphatase-controlled signaling dynamics in human cells.
SKIP CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the INPP5K gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the INPP5K together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the INPP5K open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SKIP protein expression.
This CRISPR knockout system enables efficient generation of INPP5K-deficient cell models for investigation of SKIP signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.